Latest News about FDA
Recent news which mentions FDA
Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate
February 17, 2023
From Benzinga
Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review
February 16, 2023
Tickers
PFE
From Benzinga
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
February 15, 2023
Tickers
ZLDAF
From Benzinga
From PRLog
FDA Suggests NRx Pharma's Bipolar Program To Be Enlarged For Chronic Treatment Of Patients With Suicidality
February 13, 2023
Tickers
NRXP
From Benzinga
One Analyst Is Bullish While Another Sees Overhang On Phathom Pharma Stock After Two Rejection Letters
February 10, 2023
Tickers
PHAT
From Benzinga
FDA AdComm Votes In Favor Of GSK's Jemperli Single Arm Trial Plan For Rectal Cancer Setting
February 10, 2023
Tickers
GSK
From Benzinga
FDA Slaps Partial Clinical Hold On Blueprint Medicines' Early-Stage Solid Tumor Study
February 10, 2023
Tickers
BPMC
From Benzinga
FDA Grants Complete Approval For GSK's Jemperli For Endometrial Cancer
February 10, 2023
Tickers
GSK
From Benzinga
Phathom Pharma Shares Fall After Formal FDA Request For Vonoprazan Data
February 10, 2023
Tickers
PHAT
From Benzinga
PharmaTher Seeks Regulatory Approval Of New Ketamine Delivery System For Anesthesia And Sedation
February 07, 2023
Tickers
PHRRF
From Benzinga
Sage Therapeutics-Biogen Partnered Depression Candidate Under Priority FDA Review, Analyst Says Its 'Incrementally Positive'
February 06, 2023
From Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
February 03, 2023
From Benzinga
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
February 03, 2023
Tickers
GILD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.